The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women

性欲低下障碍 医学 性欲 生殖健康 生物心理社会模型 精神科 临床心理学 人类性学 人口 环境卫生 性别研究 社会学
作者
Anita H. Clayton,Irwin Goldstein,Noel N. Kim,Stanley E. Althof,Stephanie S. Faubion,Brooke Faught,Sharon J. Parish,James A. Simon,Linda Vignozzi,Kristin Christiansen,Susan R. Davis,Murray A. Freedman,Sheryl A. Kingsberg,Paraskevi‐Sofia Kirana,Lisa Larkin,Marita P. McCabe,Richard Sadovsky
出处
期刊:Mayo Clinic Proceedings [Elsevier]
卷期号:93 (4): 467-487 被引量:216
标识
DOI:10.1016/j.mayocp.2017.11.002
摘要

The International Society for the Study of Women's Sexual Health process of care (POC) for management of hypoactive sexual desire disorder (HSDD) algorithm was developed to provide evidence-based guidelines for diagnosis and treatment of HSDD in women by health care professionals. Affecting 10% of adult females, HSDD is associated with negative emotional and psychological states and medical conditions including depression. The algorithm was developed using a modified Delphi method to reach consensus among the 17 international panelists representing multiple disciplines. The POC starts with the health care professional asking about sexual concerns, focusing on issues related to low sexual desire/interest. Diagnosis includes distinguishing between generalized acquired HSDD and other forms of low sexual interest. Biopsychosocial assessment of potentially modifiable factors facilitates initiation of treatment with education, modification of potentially modifiable factors, and, if needed, additional therapeutic intervention: sex therapy, central nervous system agents, and hormonal therapy, guided in part by menopausal status. Sex therapy includes behavior therapy, cognitive behavior therapy, and mindfulness. The only central nervous system agent currently approved by the US Food and Drug Administration (FDA) for HSDD is flibanserin in premenopausal women; use of flibanserin in postmenopausal women with HSDD is supported by data but is not FDA approved. Hormonal therapy includes off-label use of testosterone in postmenopausal women with HSDD, which is supported by data but not FDA approved. The POC incorporates monitoring the progress of therapy. In conclusion, the International Society for the Study of Women's Sexual Health POC for the management of women with HSDD provides a rational, evidence-based guideline for health care professionals to manage patients with appropriate assessments and individualized treatments.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
清脆雪巧发布了新的文献求助10
刚刚
cjhAshley发布了新的文献求助10
1秒前
1秒前
1秒前
星辰大海应助硕心采纳,获得10
2秒前
大地上的鱼完成签到,获得积分10
2秒前
2秒前
CipherSage应助完美的皮卡丘采纳,获得10
2秒前
大卜发布了新的文献求助10
2秒前
2秒前
3秒前
TangbaoOK完成签到,获得积分10
3秒前
3秒前
4秒前
可玩性发布了新的文献求助10
4秒前
李木槿发布了新的文献求助10
5秒前
5秒前
5秒前
5秒前
完美世界应助无脸男采纳,获得10
5秒前
大气亦巧完成签到,获得积分10
5秒前
甜美砖家发布了新的文献求助10
5秒前
6秒前
怡然的涫发布了新的文献求助10
7秒前
cjhAshley完成签到,获得积分10
8秒前
超级小猫咪完成签到,获得积分10
8秒前
泡泡完成签到,获得积分10
8秒前
8秒前
klony完成签到,获得积分10
9秒前
OrtonF7完成签到,获得积分20
9秒前
拼搏的白梅完成签到,获得积分10
9秒前
9秒前
小王发布了新的文献求助30
9秒前
9秒前
10秒前
duj622完成签到 ,获得积分10
10秒前
11应助zygclwl采纳,获得10
10秒前
10秒前
完美世界应助fan采纳,获得10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1000
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 1000
Russian Foreign Policy: Change and Continuity 800
Real World Research, 5th Edition 800
Qualitative Data Analysis with NVivo By Jenine Beekhuyzen, Pat Bazeley · 2024 800
Superabsorbent Polymers 700
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5710194
求助须知:如何正确求助?哪些是违规求助? 5198067
关于积分的说明 15259712
捐赠科研通 4862771
什么是DOI,文献DOI怎么找? 2610309
邀请新用户注册赠送积分活动 1560657
关于科研通互助平台的介绍 1518334